ScienceOpen research最新文献

筛选
英文 中文
The elastic modulus of isolated polytetrafluoroethylene filaments 分离聚四氟乙烯长丝的弹性模量
ScienceOpen research Pub Date : 2014-09-15 DOI: 10.14293/S2199-1006.1.SOR-MATSCI.AKA0J6.V2
Patrick Drawe, N. Lüttschwager, M. Suhm
{"title":"The elastic modulus of isolated polytetrafluoroethylene filaments","authors":"Patrick Drawe, N. Lüttschwager, M. Suhm","doi":"10.14293/S2199-1006.1.SOR-MATSCI.AKA0J6.V2","DOIUrl":"https://doi.org/10.14293/S2199-1006.1.SOR-MATSCI.AKA0J6.V2","url":null,"abstract":"We report vibrational Raman spectra of small extended perfluoro- n -alkanes (C n F 2 n +2 with n = 6, 8 – 10, 12 – 14) isolated in supersonic jet expansions and use wavenumbers of longitudinal acoustic vibrations to extrapolate the elastic modulus of cold, isolated polytetrafluoroethylene filaments. The derived value E = 209(10) GPa defines an upper limit for the elastic modulus of the perfectly crystalline, noninteracting polymer at low temperatures and serves as a benchmark for quantum chemical predictions.","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"268 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76599671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bromosubstituted Norbornadienes and Their Reversible Photolytic Transformation to Quadricyclanes 溴取代降冰片二烯及其可逆光解转化为四环烷
ScienceOpen research Pub Date : 2014-09-05 DOI: 10.14293/S2199-1006.1.SOR-CHEM.AKS7SX.V1
T. Sørensen, A. Madsen, Peter, A. Madsen, Martin, K. Bechgaard
{"title":"Bromosubstituted Norbornadienes and Their Reversible Photolytic Transformation to Quadricyclanes","authors":"T. Sørensen, A. Madsen, Peter, A. Madsen, Martin, K. Bechgaard","doi":"10.14293/S2199-1006.1.SOR-CHEM.AKS7SX.V1","DOIUrl":"https://doi.org/10.14293/S2199-1006.1.SOR-CHEM.AKS7SX.V1","url":null,"abstract":"Two new model systems for use within the rapidly develop- ing ultrafast time resolved x-ray scattering techniques have been prepared. Their photoisomerisation from norbornadiene to quadricyclane was found to be a suitable reaction to fol- low. Simulations of scattering patterns (not included in this report) showed that if heavy atoms are included in these molecular structures, then the transformation can be followed by transient X-ray scattering techniques. Two new bromosub- stituted norbornadienes were synthesised and characterised. Absorption spectroscopy showed that the norbornadienes are converted quantitatively to quadricyclanes under ultra- violet irradiation. Nuclear magnetic resonance (NMR) studies showed that the process was fully reversible and that the norbornadienes could be completely recovered even without addition of catalysts. Furthermore, it was shown that the formation of quadricyclane from norbornadiene was unaf- fected by triplet sensitisers. The two new model systems synthesised thus are strong candidates for use in time- resolved X-ray scattering studies in both gas and condensed phases.","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82484718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Head to head comparisons in performance of CD4 point-of-care assays: a Bayesian meta-analysis (2000–2013) CD4护理点检测性能的正面比较:贝叶斯荟萃分析(2000-2013)
ScienceOpen research Pub Date : 2014-07-11 DOI: 10.14293/S2199-1006.1.SOR-MED.A4QF5Y.V2
S. Wilkinson, T. Chiavegatti, B. Nauche, Given Names Deactivated Family Name Deactivated, N. Pai
{"title":"Head to head comparisons in performance of CD4 point-of-care assays: a Bayesian meta-analysis (2000–2013)","authors":"S. Wilkinson, T. Chiavegatti, B. Nauche, Given Names Deactivated Family Name Deactivated, N. Pai","doi":"10.14293/S2199-1006.1.SOR-MED.A4QF5Y.V2","DOIUrl":"https://doi.org/10.14293/S2199-1006.1.SOR-MED.A4QF5Y.V2","url":null,"abstract":"Timely detection, staging, and treatment initiation are pertinent to controlling HIV infection. CD4+ cell-based point-of-care (POC) devices offer the potential to rapidly stage patients, and decide on initiating treatment, but a comparative evaluation of their performance has not yet been performed. With this in mind, we conducted a systematic review and metaanalyses. For the period January 2000 to April 2014, 19 databases were systematically searched, 6619 citations retrieved, and 25 articles selected. Diagnostic performance was compared across devices (i.e., PIMA, CyFlow, miniPOC, MBioCD4 System) and across specimens (i.e., capillary blood vs. venous blood). A Bayesian approach was used to meta-analyze the data. The primary outcome, the Bland–Altman (BA) mean bias (which represents agreement between cell counts from POC device and flow cytometry), was analyzed with a Bayesian hierarchical normal model. We performed a headto-head comparison of two POC devices such as PIMA and PointCareNOW CD4. PIMA appears to perform better vs. PointCareNOW with venous samples (BA mean bias: –9.5 cells/μL; 95% CrI: –37.71 to 18.27, vs. 139.3 cells/μL; 95% CrI: –0.85 to 267.4, mean difference = 148.8, 95% CrI: 11.8, 285.8); however, PIMA’s best performed when used with capillary samples (BA mean bias: 2.2 cells/μL; 95% CrI: – 19.32 to 23.6). Sufficient data were available to allow pooling of sensitivity and specificity data only at the 350 cells/μL cutoff. For PIMA device sensitivity 91.6 (84.7–95.5) and specificity was 94.8 (90.1–97.3), respectively. There were not sufficient data to allow comparisons between any other devices. PIMA device was comparable to flow cytometry. The estimated differences between the CD4+ cell counts of the device and the reference was small and best estimated in capillary blood specimens. As the evidence stands, the PointCareNOW device will need to improve prior to widespread use and more data on MBio and MiniPOC are needed. Findings inform implementation of PIMA and improvements in other CD4 POC device prior to recommending widespread use. INTRODUCTION Universal access to antiretroviral therapy (ART) and increased levels of HIV testing have created hope that HIV infection can be controlled globally. Approximately 9.7 mil‐ lion people now receive ART in lowand middle-income countries, representing a 32-fold increase over the last decade [1]. Effective ART reduces viral load (VL) to undetectable levels and dramatically reduces associated mortality and morbidity [2–4]. As a public health intervention, ART is at the core of a treatment-as-prevention strategy, as reducing community viral load reduces HIV transmissions [4]. CD4+ cells counts and measures of VL are surrogate biomarkers of disease progression that help to stage, initiate and monitor treatment. CD4+ cell counts provide an immunological measure of HIV progression; these counts are utilized in the care of HIV+ patients for staging infections and in assessing patients for ART el","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"18 1","pages":"1-13"},"PeriodicalIF":0.0,"publicationDate":"2014-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75208269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The anti-coagulants ASIS or APC do not protect against renal ischemia/ reperfusion injury 抗凝剂ASIS或APC对肾缺血/再灌注损伤没有保护作用
ScienceOpen research Pub Date : 2014-06-12 DOI: 10.14293/A2199-1006.01.SOR-MED.YXBIK.V1
T. Lisman
{"title":"The anti-coagulants ASIS or APC do not protect against renal ischemia/ reperfusion injury","authors":"T. Lisman","doi":"10.14293/A2199-1006.01.SOR-MED.YXBIK.V1","DOIUrl":"https://doi.org/10.14293/A2199-1006.01.SOR-MED.YXBIK.V1","url":null,"abstract":"","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77207652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The anti-coagulants ASIS or APC do not protect against renal ischemia/ reperfusion injury 抗凝剂ASIS或APC对肾缺血/再灌注损伤没有保护作用
ScienceOpen research Pub Date : 2014-06-12 DOI: 10.14293/S2199-1006.1.SOR-MED.AYXBIK.V1
S. Loubele, Arnold Spek, P. Leenders, R. Matthijsen, W. Buurman, C. Peutz-Kootstra, H. Cate, H. Spronk
{"title":"The anti-coagulants ASIS or APC do not protect against renal ischemia/ reperfusion injury","authors":"S. Loubele, Arnold Spek, P. Leenders, R. Matthijsen, W. Buurman, C. Peutz-Kootstra, H. Cate, H. Spronk","doi":"10.14293/S2199-1006.1.SOR-MED.AYXBIK.V1","DOIUrl":"https://doi.org/10.14293/S2199-1006.1.SOR-MED.AYXBIK.V1","url":null,"abstract":"","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73430119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons learned from extracorporeal membrane oxygenation as a bridge to lung transplantation 体外膜氧合作为肺移植的桥梁的经验教训
ScienceOpen research Pub Date : 2014-05-16 DOI: 10.14293/S2199-1006.1.SOR-MED.ABG1R6.V1
V. Shumaster, O. Jawitz, D. Yuh, P. Bonde
{"title":"Lessons learned from extracorporeal membrane oxygenation as a bridge to lung transplantation","authors":"V. Shumaster, O. Jawitz, D. Yuh, P. Bonde","doi":"10.14293/S2199-1006.1.SOR-MED.ABG1R6.V1","DOIUrl":"https://doi.org/10.14293/S2199-1006.1.SOR-MED.ABG1R6.V1","url":null,"abstract":"Extracorporeal membrane oxygenation (ECMO) has been used infrequently as a bridge to lung transplantation due to lack of consensus and data regarding the benefits of such a strategy. We present data from the United Network of Organ Sharing (UNOS) database on the outcomes of patients bridged to lung transplantation with ECMO. We used the UNOS database to analyze data between January 1, 2000 and December 31, 2011. During this time 14,263 lung transplants were performed, of which 143 (1.0%) were bridged using ECMO. Patients on ECMO as a bridge to lung transplantation were compared to those transplanted without prior ECMO support. Demographics, survival rates, complications, and rejection episodes were compared between the two groups. The 30-day, 6-month, 1-year, 3-year, and 5-year survival rates were 69%, 56%, 48%, 26%, and 11%, respectively, for the ECMO bridge group and 95%, 88%, 81%, 58%, and 38% respectively, for the control group (p ≤ 0.01). The ECMO group incurred higher rate of postoperative complications, including airway dehiscence (4% vs. 1%, p ≤ 0.01), stroke (3% vs. 2%, p ≤ 0.01), infection (56% vs. 42%, p ≤ 0.01), and pulmonary embolism (10% vs. 0.6%, p ≤ 0.01). The length of hospital stay was longer for the ECMO group (41 vs. 25 days, p ≤ 0.01), and they were treated for rejection more often (49% vs. 36%, p = 0.02). The use of ECMO as a bridge to lung transplantation is associated with significantly worse survival and more frequent postoperative complications. Therefore, we advocate very careful patient selection and cautious use of ECMO.","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75454243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Lessons learned from extracorporeal membrane oxygenation as a bridge to lung transplantation 体外膜氧合作为肺移植的桥梁的经验教训
ScienceOpen research Pub Date : 2014-05-16 DOI: 10.14293/A2199-1006.01.SOR-MED.BG1R6.V1
Zhongjun J. Wu
{"title":"Lessons learned from extracorporeal membrane oxygenation as a bridge to lung transplantation","authors":"Zhongjun J. Wu","doi":"10.14293/A2199-1006.01.SOR-MED.BG1R6.V1","DOIUrl":"https://doi.org/10.14293/A2199-1006.01.SOR-MED.BG1R6.V1","url":null,"abstract":"","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"72 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74138961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
EGF/EGFR signaling axis is a significant regulator of the proteasome expression and activity in colon cancer cells EGF/EGFR信号轴是结肠癌细胞中蛋白酶体表达和活性的重要调节因子
ScienceOpen research Pub Date : 2014-05-14 DOI: 10.14293/S2199-1006.1.SOR-LIFE.AAC0E6.V2
Maria-Ioanna Ellina, P. Bouris, D. Kletsas, A. Aletras, Nikos Karamanos
{"title":"EGF/EGFR signaling axis is a significant regulator of the proteasome expression and activity in colon cancer cells","authors":"Maria-Ioanna Ellina, P. Bouris, D. Kletsas, A. Aletras, Nikos Karamanos","doi":"10.14293/S2199-1006.1.SOR-LIFE.AAC0E6.V2","DOIUrl":"https://doi.org/10.14293/S2199-1006.1.SOR-LIFE.AAC0E6.V2","url":null,"abstract":"Colon cancer is the third most common type of cancer worldwide. Epidermal growth factor receptor (EGFR) plays a crucial role in the (patho)physiology of the disease. EGFR controls vital cellular processes, while this action is associated with poor prognosis. In addition, K-Ras mutations are associated with the promotion of the disease and the anti-EGFR resistance. The ubiquitin-proteasome system plays also a very important role in cancer, modulating cell cycle and other cellular processes such as the growth and the survival of cancer cells. Proteasome inhibition affects, in several cases, the action and the protein levels of EGFR. Nevertheless, little is known whether the reversed option is possible. In this study, we, therefore, investigated the impact of epidermal growth factor (EGF)/EGFR signaling axis on gene expression and the proteolytic activity of the proteasome subunits, as well as whether Nrf2, an activator of proteasome expression, plays a role in this process. Moreover, we evaluated whether EGF regulates the expression of its own receptor and the proliferation rate of DLD-1 (K-Ras mutated) colon cancer cells. The obtained data showed that, although EGF has no significant effect on the proliferation of DLD-1 colon cancer cells, it significantly upregulates the expression of EGFR as well as the expression and the activity of the proteasome, suggesting that the EGF-mediated proteasome activation could possibly lead to enhanced EGFR degradation leading to autoregulation of EGF–EGFR pathway. Nrf2 activation did not induce proteasome gene expression in DLD-1 colon cancer cells.","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"37 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72484421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
EGF/EGFR signaling axis is a significant regulator of the proteasome expression and activity in colon cancer cells EGF/EGFR信号轴是结肠癌细胞中蛋白酶体表达和活性的重要调节因子
ScienceOpen research Pub Date : 2014-05-14 DOI: 10.14293/A2199-1006.01.SOR-LIFE.AC0E6.V1
S. Tanida
{"title":"EGF/EGFR signaling axis is a significant regulator of the proteasome expression and activity in colon cancer cells","authors":"S. Tanida","doi":"10.14293/A2199-1006.01.SOR-LIFE.AC0E6.V1","DOIUrl":"https://doi.org/10.14293/A2199-1006.01.SOR-LIFE.AC0E6.V1","url":null,"abstract":"","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"83 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73103966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
FASTA Herder: a web application to trim protein sequence sets FASTA Herder:一个修剪蛋白质序列集的web应用程序
ScienceOpen research Pub Date : 2014-04-29 DOI: 10.14293/S2199-1006.1.SOR-LIFE.A67837.V2
M. Andrade, Caroline Louis-Jeune, C. Perez-Iratxeta
{"title":"FASTA Herder: a web application to trim protein sequence sets","authors":"M. Andrade, Caroline Louis-Jeune, C. Perez-Iratxeta","doi":"10.14293/S2199-1006.1.SOR-LIFE.A67837.V2","DOIUrl":"https://doi.org/10.14293/S2199-1006.1.SOR-LIFE.A67837.V2","url":null,"abstract":"Abstract\u0000The ever increasing number of sequences in protein databases usually turns out large numbers of homologs in sequence similarity searches. While information from homology can be very useful for functional prediction based on amino acid conservation, many of these homologs usually have high levels of identity among themselves, which hinders multiple sequence alignment computation and, especially, visualization. More generally, high redundancy reduces the usability of a protein set in machine learning applications and biases statistical analyses. We developed an algorithm to identify redundant sequence homologs that can be culled producing a streamlined FASTA file. As a difference from other automatic approaches that only aggregate sequences with high identity, our method clusters near-full length homologs allowing for lower sequence identity thresholds. Our method was fully tested and implemented in a web application called FASTA Herder, publicly available at http://fh.ogic.ca/.","PeriodicalId":91169,"journal":{"name":"ScienceOpen research","volume":"138 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2014-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88723664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书